Good Evening Market Enthusiast,

Clear your calendar. Set an alarm. ⏰

Because tomorrow at 8AM EST, something big is dropping and you’ll want to be ahead of it.

We’re talking about a tiny biotech that’s doing everything right in a space that couldn’t be more urgent.

💥 Clean human trial safety data just hit
💥 Multiple viruses, one drug—and it works in preclinical models
💥 Global-scale production already underway
💥 Real funding runway + multiple paths to more, without dilution

This isn’t a “maybe someday” story.

This is ready now, and still flying under Wall Street’s radar.

👉 Tomorrow’s reveal will show you why that won’t last.

The company is:

✅ Taking on mutating viruses with a smarter, harder-to-evade solution
✅ Already approved to launch trials where others are years behind
✅ Making their own drug—in-house, GMP-certified, scale-ready
✅ Not just another vaccine angle—this is platform tech with range

And best of all?

Nobody’s watching… yet.

But after tomorrow, that’s going to change. Fast.

If you like asymmetric setups, viral catalysts, and real biotech execution…

You need to be watching at 8AM.

This is the one people will wish they caught early.

Get ready.

Tomorrow it’s go time.

Max Masters

Co-founder, Market Tips Newsletter

Paid Promotion. Please read Momentum Media LLC’s complete disclaimer at https://markettips.net/disclaimer/ which includes important information. Emojis, graphics and/or images used herein have no specific or implied meaning, and are used for artistic purposes only. Nothing contained herein is fina.ncial advice. Momentum Media LLC is not an analyst, st.o.ck broker, fina.ncial adviser or st.o.ck picker nor is it qualified to act in the capacity of any of the foregoing. Information herein is a paid advertisement and should not be relied upon as accurate or complete.